Patient Rating:

No Rating Available?

Francis M. Filloux, M.D.

Chief, Division of Pediatric Neurology

Patient Rating:

No Rating Available?



  • English
  • French
  • Spanish

Clinical Details

Phone Number Clinical Office Address
(801) 213-3599
Eccles Primary Children’s Outpatient Services Building
81 N Mario Capecchi Drive
Salt Lake City, UT 84113
(801) 213-3599
PCH Outpatient Services at Riverton
3773 West 12600 South
Riverton, UT 84065


Francis Filloux, MD is Chief of the Division of Pediatric Neurology at the University of Utah School of Medicine and Primary Children’s Medical Center. He is responsible for administering the Division of Pediatric Neurology and is Program Training Director for the Pediatric Neurology Residency Program. Dr. Filloux is a general child neurologist who sees children with all forms of neurological disease, having special interest in tic disorders, Tourette's, and neurobehavioral problems.

Board Certification and Academic Information

Academic Departments Pediatrics - Professor
Neurology - Professor
Academic Divisions Pediatric Neurology
Board Certification American Board of Psychiatry & Neurology (Sub: Child/Adol)
American Board of Pediatrics (Pediatrics)
National Board of Medical Examiners

Academic Profile

Board Certification and Academic Information

Academic Departments Pediatrics - Professor
Neurology - Professor
Academic Divisions Pediatric Neurology
Board Certification American Board of Psychiatry & Neurology (Sub: Child/Adol)
American Board of Pediatrics (Pediatrics)
National Board of Medical Examiners

Academic Office Locations

Academic Office Phone Number Academic Office Address
(801) 213-3599 Eccles Primary Children’s Outpatient Services Building
Pediatric Neurology
81 N Mario Capecchi Drive
Salt Lake City, UT 84113

Academic Bio

Francis M. Filloux, M.D. is the Chief of Pediatric Neurology at the University of Utah and Primary Children’s Medical Center in Salt Lake City, UT where he directs a vibrant, growing subspecialty group dedicated to the care of children with neurological disorders throughout the Intermountain West. He has been the Program Training Director for the Pediatric Neurology residency program, and is an active clinician and educator. Dr. Filloux’ current scholarly interests include pediatric neurology education, health care quality and improvement with reference to the neurological care for children, and the seizure and neurological characteristics of children with congenital genetic syndromes.

Dr. Filloux received his undergraduate education at the University of California, San Diego and his M.D. from University of California, Los Angeles School of Medicine. After completing postgraduate training in pediatrics and neurology with specialization in child neurology at the University of Utah, he served as a post-doctoral fellow in neuropharmacology under the direction of James Wamsley, Ph.D. During the first phase of his academic career he studied the neurochemical development of the basal ganglia and the ontogeny of calcium channels in vertebrate brain. He has developed specialized expertise in the evaluation and care of children with movement disorders, including Tourette syndrome and related conditions.

He currently serves on the editorial board of the Journal of Child Neurology and continues to find enjoyment in teaching medical students, residents and colleagues in the principles of neurological evaluation and diagnosis and in the breadth of clinical problems in pediatric neurology. His greatest professional satisfaction relates to the recruitment and training of bright young pediatric neurologists here at the University of Utah.


Education History

Type School Degree
Certification Intermountain Institute for Health Care Delivery Research
Mini-Advanced Training Program in Health Care Delivery Improvement
Post Graduate Training Leadership Development Program for Faculty and Director Staff, University of Utah
Post Graduate Training David Eccles School of Business, Leadership Development for Physician Executives. University of Utah
Fellowship University of Utah School of Medicine
Chief Resident University of Utah School of Medicine
Pediatric Neurology
Chief Resident
Residency University of Utah School of Medicine
Pediatric Neurology
Residency University of Utah School of Medicine
Internship University of Utah School of Medicine
Professional Medical University of California - Los Angeles
Undergraduate University of California at San Diego


Selected Provider Publications

Journal Article

  1. Roundy LM, Filloux FM, Kerr L, Rimer A, Bonkowsky JL (2016). Seizure Action Plans Do Not Reduce Health Care Utilization in Pediatric Epilepsy Patients. J Child Neurol, 31(4), 433-8.
  2. Devinsky O, Marsh E, Friedman D, Thiele E, Laux L, Sullivan J, Miller I, Flamini R, Wilfong A, Filloux F, Wong M, Tilton N, Bruno P, Bluvstein J, Hedlund J, Kamens R, Maclean J, Nangia S, Singhal NS, Wilson CA, Patel A, Cilio MR (2016). Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial. Lancet Neurol, 15(3), 270-8.
  3. Byrne S, Jansen L, U-King-Im JM, Siddiqui A, Lidov HG, Bodi I, Smith L, Mein R, Cullup T, Dionisi-Vici C, Al-Gazali L, Al-Owain M, Bruwer Z, Al Thihli K, El-Garhy R, Flanigan KM, Manickam K, Zmuda E, Banks W, Gershoni-Baruch R, Mandel H, Dagan E, Raas-Rothschild A, Barash H, Filloux F, Creel D, Harris M, Hamosh A, Kolker S, Ebrahimi-Fakhari D, Hoffmann GF, Manchester D, Boyer PJ, Manzur AY, Lourenco CM, Pilz DT, Kamath A, Prabhakar P, Rao VK, Rogers RC, Ryan MM, Brown NJ, McLean CA, Said E, Schara U, Stein A, Sewry C, Travan L, Wijburg FA, Zenker M, Mohammed S, Fanto M, Gautel M, Jungbluth H (2016). EPG5-related Vici syndrome: a paradigm of neurodevelopmental disorders with defective autophagy. Brain, 139(Pt 3), 765-81.
  4. Filloux FM, Hoffman RO, Viskochil DH, Jungbluth H, Creel DJ (2014). Ophthalmologic features of Vici syndrome. J Pediatr Ophthalmol Strabismus, 51(4), 214-20.
  5. Stockmann C, Ampofo K, Byington CL, Filloux F, Hersh AL, Blaschke AJ, Cowan P, Korgenski K, Mason EO, Pavia AT (2013). Pneumococcal meningitis in children: epidemiology, serotypes, and outcomes from 1997-2010 in Utah. Pediatrics, 132(3), 421-8.
  6. Cullup T, Kho AL, Dionisi-Vici C, Brandmeier B, Smith F, Urry Z, Simpson MA, Yau S, Bertini E, McClelland V, Al-Owain M, Koelker S, Koerner C, Hoffmann GF, Wijburg FA, ten Hoedt AE, Rogers RC, Manchester D, Miyata R, Hayashi M, Said E, Soler D, Kroisel PM, Windpassinger C, Filloux FM, Al-Kaabi S, Hertecant J, Del Campo M, Buk S, Bodi I, Goebel HH, Sewry CA, Abbs S, Mohammed S, Josifova D, Gautel M, Jungbluth H (2013). Recessive mutations in EPG5 cause Vici syndrome, a multisystem disorder with defective autophagy. Nat Genet, 45(1), 83-7.
  7. Filloux FM, Carey JC, Krantz ID, Ekstrand JJ, Candee MS (2012). Occurrence and clinical features of epileptic and non-epileptic paroxysmal events in five children with Pallister-Killian syndrome. Eur J Med Genet, 55(5), 367-73.
  8. Candee MS, Carey JC, Krantz ID, Filloux FM (2012). Seizure characteristics in Pallister-Killian syndrome. Am J Med Genet A, 158A(12), 3026-32.
  9. Bonkowsky JL, Nelson C, Kingston JL, Filloux FM, Mundorff MB, Srivastava R (2010). The Burden of Inherited Leukodystrophies in Children. Neurology, 75(8), 718-725.
  10. Holsti M, Dudley N, Schunk J, Adelgais K, Greenberg R, Olsen C, Healy A, Firth S, Filloux F (2010). Intranasal midazolam vs rectal diazepam for the home treatment of acute seizures in pediatric patients with epilepsy. Arch Pediatr Adolesc Med, 164(8), 747-53.
  11. Singh NA, Pappas C, Dahle EJ, Claes LR, Pruess TH, De Jonghe P, Thompson J, Dixon M, Gurnett C, Peiffer A, White HS, Filloux F, Leppert MF (2009). A role of SCN9A in human epilepsies, as a cause of febrile seizures and as a potential modifier of Dravet syndrome. PLoS Genet, 5(9), e1000649.
  12. Bonkowsky JL, Guenther E, Srivastava R, Filloux FM (2009). Seizures In Children Following an Apparent Life-threatening Event. J Child Neurol, 24(6), 709-13.
  13. Bonkowsky JL, Guenther E, Filloux FM, Srivastava R (2008). Death, child abuse, and adverse neurological outcome of infants after an apparent life-threatening event. Pediatrics, 122(1), 125-31.
  14. Bonkowsky JL, Filloux FM, Warner JE (2007). Splenial corpus callosum lesion and hemifield visual color anomia associated with intracranial hypertension. J Child Neurol, 22(9), 1132-4.
  15. Holsti M, Sill BL, Firth SD, Filloux FM, Joyce SM, Furnival RA (2007). Prehospital intranasal midazolam for the treatment of pediatric seizures. Pediatr Emerg Care, 23(3), 148-53.
  16. Caplin DA, Rao JK, Filloux F, Bale JF, Van Orman C (2006). Development of performance indicators for the primary care management of pediatric epilepsy: expert consensus recommendations based on the available evidence. Epilepsia, 47(12), 2011-9.
  17. Bonkowsky JL, Filloux FM, Byington CL (2006). Herpes simplex virus central nervous system relapse during treatment of infantile spasms with corticotropin. Pediatrics, 117(5), e1045-8.
  18. Henderson CB, Filloux FM, Alder SC, Lyon JL, Caplin DA (2006). Efficacy of the ketogenic diet as a treatment option for epilepsy: meta-analysis. J Child Neurol, 21(3), 193-8.
  19. Thompson JA, Filloux FM, Van Orman CB, Swoboda K, Peterson P, Firth SD, Bale JF Jr (2005). Infant botulism in the age of botulism immune globulin. Neurology, 64(12), 2029-32.
  20. Benedict SL, Bonkowsky JL, Thompson JA, Van Orman CB, Boyer RS, Bale JF Jr, Filloux FM (2004). Case Series-Cerebral sinovenous thrombosis in children: another reason to treat iron deficiency anemia. J Child Neurol, 19(7), 526-31.
  21. Singh NA, Westenskow P, Charlier C, Pappas C, Leslie J, Dillon J, The BFNC Physician Consortium Filloux FM, et al Lepper MF (2003). KCNQ2 and KCNQ3 Potassium Channel Genes in Benign Familial Neonatal Convulsions: Expansion of the functional and Mutation Spectrum. Brain, 126, 2726-2737.
  22. Cannon G, Caravati EM, Filloux F (2003). Hydrogen Peroxide Neurotoxicity in Childhood: Case Report with Unique MRI Features. J Child Neurol, 18, 805-8.


  1. Filloux FM (2015). Cannabinoids for pediatric epilepsy? Up in smoke or real science? [Review]. Transl Pediatr, 4(4), 271-82.
  2. McMahon WM, Filloux FM, Ashworth JC, Jensen J (2002). Movement disorders in children and adolescents. [Review]. Neurol Clin, 20(4), 1101-24, vii-viii.

Book Chapter

  1. McMahon WM, Leppert M, Filloux F, van de Wetering BJM, Hasstedt S (1992). Tourette Symptoms in 161 Related Family Members. In Chase TN, Friedhoff AJ, Cohen DJ (Eds.), Tourette Syndrome: Genetics, Neurobiology and Treatment (58, pp. 159-165). New York: Adv. Neurol, Raven Press.


  1. Wilson CA, Spigarelli M, Sweney M, Van Orman C, Alger F, Merrill S, Skidmore J, Filloux F (October 2015). Efficacy, Adverse Effects, and Additional Benefits of Epidiolex in Children and Young Adults withTreatment Resistant Epilepsy [Abstract]. Annals of Neurology, 78((suppl 19)), S180.
  2. Roundy LM, Filloux FM, Kerr L, Rimer A, Bonkowsky JL (October 2014). Seizure Action Plans Do Not Reduce Healthcare Utilization in Pediatric Seizure Patients [Abstract]. Annals of Neurology, 76(S18), S200.
  3. Rimer A, Filloux, F, Rogers JE, Rimer EG, Hughes AM, Kerr, LM (October 2014). Improving Communication of Imaging Results to Families: a quality improvement project [Abstract]. Annals of Neurology, 76(S18), S184.

Clinical Trials

Clinical Trials

Video & News

The Scope Health Sciences Radio